Showing results (1741-1750 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|February 1, 2015
Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble formAlessia Pagani, Maud Vieillevoye, Antonella Nai, et al.Haematologica|February 1, 2015
GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6Leo Rasche, Johannes Duell, Inês C Castro, et al.Haematologica|February 1, 2015
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsValérie Bardet, Orianne Wagner-Ballon, Julien Guy, et al.Haematologica|February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trialNicolas Boissel, Aline Renneville, Thibaut Leguay, et al.Haematologica|February 26, 2015
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myelomaJessica Bordini, Maria Teresa Sabrina Bertilaccio, Maurilio Ponzoni, et al.Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.Haematologica|April 28, 2018
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.Haematologica|December 17, 2009
Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cellsTom Lenaerts, Jorge M Pacheco, Arne Traulsen, et al.Haematologica|December 17, 2009
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibodyNicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, et al.Pageof 816